Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

about

Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

Item

http://www.wikidata.org/entity/Q39668588

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

@en

Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

@nl

type

Item

label

Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

@en

Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

@nl

prefLabel

Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

@en

Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers.

@nl

P1476

Efficient Protocol for the Identification of Hypoxic Cell Radiosensitisers

@en

P2093

Cho Rong Hong

http://www.w3.org/2001/XMLSchema#string

Jingli Wang

http://www.w3.org/2001/XMLSchema#string

Kevin O Hicks

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperbaric oxygenation for tumour sensitisation to radiotherapy

Tricyclic [1,2,4]triazine 1,4-dioxides as hypoxia selective cytotoxins

Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers

Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene

Exploiting tumour hypoxia in cancer treatment

Tirapazamine, cisplatin, and radiation versus cisplatin and radiation for advanced squamous cell carcinoma of the head and neck (TROG 02.02, HeadSTART): a phase III trial of the Trans-Tasman Radiation Oncology Group

Hypoxia in cancer: significance and impact on clinical outcome

Regulation of cancer cell metabolism

Targeting hypoxia in cancer therapy

Phase II study of the safety and antitumor activity of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma

P304

269-290

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-3-319-26666-4_16

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

899

http://www.w3.org/2001/XMLSchema#string

P50

Michael P. Hay

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27325273

http://www.w3.org/2001/XMLSchema#string

P921

hypoxia